SuperCrowd
New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
BioEclipse Therapeutics, Inc.
bioeclipse.com · DE · Filed Jan 19, 2022
BioEclipse Therapeutics, Inc. filed a Form C — new offering — with the SEC on Jan 19, 2022. The Regulation Crowdfunding offering seeks $10,001, up to a maximum of $1,069,998 on Netcapital. Investors receive: Common Stock at $2.55. The offering closes Jan 3, 2022.
| Target raise | $10,001 |
|---|---|
| Maximum raise | $1,069,998 |
| Security | Common Stock @ $2.55 |
| Closes | Jan 3, 2022 |
| Portal | Netcapital |
| SEC file number | 020-29552 · every filing in this offering |
Filing documents
OFFERING STATEMENT PDF
OFFERING PAGE JPG
CPA REVIEW REPORT
CERTIFICATE OF INCORPORATION
CORPORATE BYLAWS
ADDITIONAL INFORMATION
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.